Skip to main content
Human Metabolome Technologies, Inc. logo

Human Metabolome Technologies, Inc. — Investor Relations & Filings

Ticker · 6090 ISIN · JP3794530000 T Professional, scientific and technical activities
Open in API
Filings indexed 73 across all filing types
Latest filing 2023-09-25 Regulatory Filings
Country JP Japan
Listing T 6090

About Human Metabolome Technologies, Inc.

https://humanmetabolome.com/

Human Metabolome Technologies, Inc. is a biotechnology company specializing in metabolomics. As a pioneer and global leader in the field, it leverages proprietary capillary electrophoresis mass spectrometry (CE-MS) based technology for comprehensive metabolome analysis. The company provides a range of analytical services, including global profiling, targeted assays, metabolic flux analysis, and lipidomics. These services support research and development projects, particularly in biomarker discovery and drug development, by delivering high-quality metabolomics data to address complex scientific and medical challenges.

Recent filings

Filing Released Lang Actions
内部統制報告書－第20期(2022/07/01－2023/06/30)
Regulatory Filings
2023-09-25 Japanese
確認書
Regulatory Filings
2023-09-25 Japanese
有価証券報告書－第20期(2022/07/01－2023/06/30)
Annual Report
2023-09-25 Japanese
確認書
Regulatory Filings Classification · 95% confidence The document is titled '確認書' (Confirmation Letter) and explicitly states it is filed under the Financial Instruments and Exchange Act Article 24-4-8. It serves as an officer certification confirming the accuracy of the quarterly report, rather than being the quarterly report itself. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS). Q3 2023
2023-05-12 Japanese
四半期報告書－第20期第3四半期(2023/01/01－2023/03/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed under the Financial Instruments and Exchange Act in Japan. It contains detailed financial statements, including the balance sheet, income statement, and segment information for the third quarter of the fiscal year 2023. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2023
2023-05-12 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is titled '確認書' (Confirmation Letter) and explicitly references '金融商品取引法第24条の４の８第１項' (Article 24-4-8, Paragraph 1 of the Financial Instruments and Exchange Act). It serves as an officer certification confirming the accuracy of the quarterly report. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type like a quarterly report. Q2 2022
2023-02-14 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.